NCT06989866
RCT to Test Regional Anesthesia Effect on Decreased Opiate Use
Enrolling by Invitation
PHASE3Ages 18+InterventionalTreatmentUnited States Naval Medical Center, PortsmouthGovernment-funded
~50 participants
Updated 2025-10-09 on ClinicalTrials.gov
What's tested:BupivacaineSaline (NaCl 0,9 %) (placebo)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Use of Opiate Pain Medications After Rhinoplasty
Measured over 1 week
Conditions
Where it's being run
1 sites across 1 statesVirginia1
Study leadership
- Tokunbo I Ayeni, MD · PRINCIPAL_INVESTIGATOR · United States Naval Medical Center, Portsmouth
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients receiving a primary septorhinplasty at NMCP or Langley Air Force Base
Exclusion
History of alcohol abuse/dependence, mental health medications or opiate use disorder. Revision surgery
What this trial measures
- Use of Opiate Pain Medications After Rhinoplasty1 week
How many opiate pills are used after rhinoplasty